نتائج البحث - "Michal Hrnčiarik"

1

دورية أكاديمية

Real‐life effectiveness of first‐line anticancer treatments in stage IIIB/IV NSCLC patients: Data from the Czech TULUNG Registry

المؤلفون: Kristian Brat, Monika Bratova, Jana Skrickova, Magda Barinova, Karolina Hurdalkova, Milos Pesek, Libor Havel, Leona Koubkova, Michal Hrnciarik, Jana Krejci, Ondrej Fischer, Milada Zemanova, Helena Coupkova, Martin Svaton

المصدر: Thoracic Cancer, Vol 11, Iss 11, Pp 3346-3356 (2020)

مصطلحات موضوعية: Anticancer treatment, non‐small cell lung cancer, progression‐free survival, real‐life effectiveness, tyrosinkinase inhibitors, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1759-7706; https://doaj.org/toc/1759-7714

URL الوصول: https://doaj.org/article/cbc351e845594ab6848729e0cc8a090b

View record at Wiley

Find this article in full text from ProQuest

Full Text Finder

2

Lung Cancer in Non-smokers in Czech Republic: Data from LUCAS Lung Cancer Clinical Registry

المصدر: Anticancer Research. 41:5549-5556

مصطلحات موضوعية: Adult, Male, Czech, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Time Factors, Population, Disease, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Internal medicine, Biomarkers, Tumor, medicine, Humans, Prospective Studies, Registries, Radical surgery, Stage (cooking), Pneumonectomy, Lung cancer, education, Survival rate, Aged, Czech Republic, Neoplasm Staging, Aged, 80 and over, education.field_of_study, Smokers, business.industry, Non-Smokers, General Medicine, Middle Aged, medicine.disease, Small Cell Lung Carcinoma, language.human_language, respiratory tract diseases, 3. Good health, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Mutation, language, Adenocarcinoma, Female, Ex-Smokers, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f45687a837ce2677c1d91847fb2d1fe
https://doi.org/10.21873/anticanres.15368

3

Prognostic Value ofEGFRExon-20 Insertions in Czech Patients With Advanced Non-small Cell Lung Cancer

المصدر: Anticancer Research. 41:5625-5634

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Mutation, biology, business.industry, Retrospective cohort study, General Medicine, medicine.disease_cause, medicine.disease, Exon, Internal medicine, Cohort, medicine, biology.protein, Non small cell, Epidermal growth factor receptor, business, Lung cancer, Tyrosine kinase

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::aba859470439e22e1b459a0e725153a0
https://doi.org/10.21873/anticanres.15378

4

Comparison of Chemotherapeutic Regimens Frequently Used in Metastatic Non-squamous NSCLC Treatment

المؤلفون: Magda Barinova, Jana Skrickova, P. Opálka, Miloš Pešek, M. Černovská, Martin Safanda, Karolina Hurdalkova, Helena Coupkova, Martin Svaton, Daniel Krejci, Milada Zemanova, Monika Bratová, Michal Hrnčiarik, Daniel Dolezal, J. Krejčí, Petra Zemanova, Leona Koubková, Juraj Kultan, Ondrej Fischer

المصدر: Anticancer Research. 41:2597-2603

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::057bcac6de29fe9f3a3ce1185eafb469
https://doi.org/10.21873/anticanres.15039

5

Real-life Effectiveness of Afatinib Versus Gefitinib in Patients With Non-small-cell Lung Cancer: A Czech Multicentre Study

المؤلفون: Monika Bratová, Daniel Dolezal, Michal Hrnčiarik, Marketa Cernovska, Magda Barinova, Tana Tuzova, Milada Zemanova, Martin Svaton, Ondrej Fischer, Jana Krejčí, Helena Čoupková, Jana Skrickova, Karolina Hurdalkova, Bedrich Porzer, Leona Koubková

المصدر: Anticancer Research. 41:2059-2065

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::4331a04cd5136e45149536b6038b4c3d
https://doi.org/10.21873/anticanres.14975

6

Real‐life effectiveness of first‐line anticancer treatments in stage IIIB/IV NSCLC patients: Data from the Czech TULUNG Registry

المؤلفون: Martin Svaton, Kristián Brat, Libor Havel, Magda Barinova, Leona Koubková, Helena Čoupková, Jana Skrickova, Ondrej Fischer, Michal Hrnčiarik, Karolina Hurdalkova, Milada Zemanova, Jana Krejčí, Monika Bratová, Miloš Pešek

المصدر: Thoracic Cancer, Vol 11, Iss 11, Pp 3346-3356 (2020)
Thoracic Cancer

مصطلحات موضوعية: Male, 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, non‐small cell lung cancer, medicine.medical_specialty, Lung Neoplasms, Bevacizumab, Afatinib, lcsh:RC254-282, 03 medical and health sciences, 0302 clinical medicine, Gefitinib, Carcinoma, Non-Small-Cell Lung, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Registries, Progression-free survival, tyrosinkinase inhibitors, Survival analysis, Czech Republic, Neoplasm Staging, business.industry, progression‐free survival, Original Articles, General Medicine, Anticancer treatment, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Survival Analysis, 3. Good health, Regimen, 030104 developmental biology, Pemetrexed, 030220 oncology & carcinogenesis, real‐life effectiveness, Female, Original Article, Erlotinib, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1621c2d5fc04c794121b2b22badc5ff
https://doaj.org/article/cbc351e845594ab6848729e0cc8a090b

View record at Wiley

Find this article in full text from ProQuest

7

Impact of Concomitant Medication Administered at the Time of Initiation of Nivolumab Therapy on Outcome in Non-small Cell Lung Cancer

المؤلفون: Magda Barinova, Bohuslav Melichar, Karolina Hurdalkova, Martin Svaton, Jiri Blazek, Lenka Jakubíková, M. Černovská, Michal Jirousek, Daniel Krejci, Jana Skrickova, Milada Zemanova, J. Krejčí, Petra Zemanova, Michal Hrnčiarik, Ondrej Bilek, Ondrej Fischer, Juraj Kultan

المصدر: Anticancer Research. 40:2209-2217

مصطلحات موضوعية: Male, Oncology, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Kaplan-Meier Estimate, 03 medical and health sciences, Route of administration, 0302 clinical medicine, Adrenal Cortex Hormones, Carcinoma, Non-Small-Cell Lung, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Outcome Assessment, Health Care, Humans, Medicine, Lung cancer, Aged, Proportional Hazards Models, Retrospective Studies, Aged, 80 and over, Univariate analysis, business.industry, Probiotics, Anti-Inflammatory Agents, Non-Steroidal, Cancer, Proton Pump Inhibitors, Retrospective cohort study, General Medicine, Middle Aged, medicine.disease, Metformin, Anti-Bacterial Agents, 3. Good health, Nivolumab, 030220 oncology & carcinogenesis, Concomitant, Female, Hydroxymethylglutaryl-CoA Reductase Inhibitors, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4470fb7f205d242846a16e4aa39f0ebb
https://doi.org/10.21873/anticanres.14182

8

Progression-free survival with first line treatment as prognostic factor of treatment success in subsequent lines in lung adenocarcinoma patients – who´s the 'good responder'?

المؤلفون: Martin Svaton, Michal Hrnčiarik, Leona Koubková, Jana Skrickova, Monika Bratová, Daniel Dolezal, Jana Krejčí, Libor Havel, Martin Safanda, Helena Čoupková, Magda Barinova, Marketa Cernovska, Juraj Kultan, Kristián Brat, Ondrej Fischer, Tana Tuzova, Milada Zemanova, Karolina Hurdalkova, Miloš Pešek

المصدر: Lung cancer.

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Prognostic factor, Lung, business.industry, medicine.disease, First line treatment, medicine.anatomical_structure, Treatment success, Internal medicine, medicine, Adenocarcinoma, Progression-free survival, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::a4c505604a7e449adfb38275957c2e3e
https://doi.org/10.1183/13993003.congress-2021.pa2306

9

Chronic Inflammation as a Potential Predictive Factor of Nivolumab Therapy in Non-small Cell Lung Cancer

المؤلفون: Martin Svaton, Renata Chloupková, Lenka Jakubíková, Milada Zemanova, Juraj Kultan, František Salajka, Bohuslav Melichar, Vitezslav Kolek, Alzbeta Bejckova, Marek Konecny, Michal Hrnčiarik, Leona Koubková, Jana Skrickova, Miloš Pešek, David Vrána

المصدر: Anticancer Research. 38:6771-6782

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c44ed53bdb4580af0981f40e07a40ef
https://doi.org/10.21873/anticanres.13048

10

Epidermal growth factor receptor (EGFR) gene mutation testing prior to tyrosine kinase inhibitors (TKI) treatment – prospective data from the Czech TULUNG registry

المصدر: Lung cancer.

مصطلحات موضوعية: biology, business.industry, Cancer research, biology.protein, Prospective data, Medicine, Epidermal growth factor receptor, business, EGFR Gene Mutation, Tyrosine kinase

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::a2833426f28ae422179024c6b9b999dc
https://doi.org/10.1183/13993003.congress-2020.1686

تنقيح النتائج